Literature DB >> 35362818

Serum irisin concentration in patients with bladder cancer.

Tomoyuki Kawada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35362818     DOI： 10.1007/s11255-022-03199-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  5 in total

1.  The diagnostic and prognostic roles of serum irisin in bladder cancer.

Authors:  Marwa M Esawy; Khalid M Abdel-Samd
Journal:  Curr Probl Cancer       Date:  2019-11-20       Impact factor: 3.187

2.  Synergism Effects of Ursolic Acid Supplementation on the Levels of Irisin, C-reactive Protein, IL-6, and TNF-α During High-intensity Resistance Training in Low Activity Men.

Authors:  Ehsan Asghari; Amir Rashidlamir; Seyyed R A Hosseini; Mahtab Moazzami; Saeed Samarghandian; Tahereh Farkhondeh
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2020

3.  Serum irisin is a novel biomarker for bladder cancer detection.

Authors:  Kerem Taken; Rahmi Aslan; Recep Eryilmaz; Hamit Hakan Alp; Zübeyir Huyut; Muhammet İrfan Dönmez
Journal:  Int Urol Nephrol       Date:  2021-11-22       Impact factor: 2.370

Review 4.  Exercise-induced myokines and their effect on prostate cancer.

Authors:  Jin-Soo Kim; Daniel A Galvão; Robert U Newton; Elin Gray; Dennis R Taaffe
Journal:  Nat Rev Urol       Date:  2021-06-22       Impact factor: 14.432

Review 5.  Effect of Chronic Resistance Training on Circulating Irisin: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Pedro L Cosio; Manuel Crespo-Posadas; Álvaro Velarde-Sotres; Mireia Pelaez
Journal:  Int J Environ Res Public Health       Date:  2021-03-03       Impact factor: 3.390
  5 in total
  1 in total

1.  Response to Letter to the Editor 'Serum irisin concentration in patients with bladder cancer'.

Authors:  Kerem Taken; Rahmi Aslan; Recep Eryilmaz; Hamit Hakan Alp; Zübeyir Huyut; Muhammet İrfan Dönmez
Journal:  Int Urol Nephrol       Date:  2022-04-20       Impact factor: 2.370
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.